• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种使用 BD PhaSeal™ 系统和危害药物小瓶中的压力的简单兼容性检查方法。

Development of a simple compatibility inspection method using pressure in a BD PhaSeal™ system and hazardous drug vials.

机构信息

St. Luke's International Hospital, Tokyo, Japan.

Showa Pharmaceutical University, Machida, Tokyo, Japan.

出版信息

J Oncol Pharm Pract. 2021 Sep;27(6):1321-1327. doi: 10.1177/1078155220952518. Epub 2020 Aug 27.

DOI:10.1177/1078155220952518
PMID:32854576
Abstract

BACKGROUND

Many reports support the use of closed system drug transfer devices (CSTDs) to protect against exposure to hazardous drugs during their preparation. However, leakage may occur if the CSTD fails to maintain hermeticity when fitted into the vial. Our aims were to devise a measure to prevent HD exposure and to develop a test method to verify CSTD function when a BD PhaSeal™ protector is used in HD preparation.

METHODS

We selected the BD PhaSeal™ System, which is the most commonly used CSTD device in Japan. The sealability of the BD PhaSeal™ protector and vial is considered to be due to the hermeticity of the protector and the rubber stopper of the vial. We constructed a protector with a damaged sealing rim and monitored the pressure fluctuation 10 times when the BD PhaSeal™ injector was connected to the pressurized vial.

RESULTS

The reduction in pressure of the protector in the group without a damaged sealing rim was 5%, while that in the group with the damaged sealing rim was 84.9%.

CONCLUSION

It was suggested that leakage occurred through the gap between the protector and the rubber stopper when using a vial that was not in close contact with the sealing rim. In this study, we developed a test that can be easily used to verify the compatibility of the BD PhaSeal™ protector and a vial in the clinical setting. Thus, when new hazardous drugs are being prepared, these measures can be taken to ensure that the risk of exposure is reduced or eliminated.

摘要

背景

许多报告都支持使用密闭式药物传输装置(CSTD)来防止在准备过程中接触危险药物。然而,如果 CSTD 在安装到小瓶时未能保持密封,可能会发生泄漏。我们的目的是设计一种措施来预防接触危险药物,并开发一种测试方法来验证 BD PhaSeal™ 保护器在用于危险药物准备时 CSTD 的功能。

方法

我们选择了 BD PhaSeal™ 系统,这是日本最常用的 CSTD 装置。BD PhaSeal™ 保护器和小瓶的密封性能被认为是由于保护器和小瓶橡胶塞的密封性。我们构建了一个带有损坏密封边缘的保护器,并在将 BD PhaSeal™ 注射器连接到加压小瓶时监测了 10 次压力波动。

结果

没有损坏密封边缘的组的保护器压力降低了 5%,而有损坏密封边缘的组的保护器压力降低了 84.9%。

结论

当使用与密封边缘没有紧密接触的小瓶时,泄漏似乎是通过保护器和橡胶塞之间的间隙发生的。在这项研究中,我们开发了一种可以在临床环境中轻松使用的测试方法,以验证 BD PhaSeal™ 保护器和小瓶的兼容性。因此,当准备新的危险药物时,可以采取这些措施来降低或消除接触危险药物的风险。

相似文献

1
Development of a simple compatibility inspection method using pressure in a BD PhaSeal™ system and hazardous drug vials.开发一种使用 BD PhaSeal™ 系统和危害药物小瓶中的压力的简单兼容性检查方法。
J Oncol Pharm Pract. 2021 Sep;27(6):1321-1327. doi: 10.1177/1078155220952518. Epub 2020 Aug 27.
2
[Pressure Compatibility Test of Closed System Drug Transfer Devices for 71 Anticancer Drugs].[71种抗癌药物的密闭式药物转移装置压力兼容性测试]
Yakugaku Zasshi. 2021;141(1):143-150. doi: 10.1248/yakushi.20-00188.
3
Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process.在药剂科配制区使用密闭式药物传递装置和去污流程进行抗肿瘤药物污染表面水平的干预前后研究。
Regul Toxicol Pharmacol. 2018 Jun;95:1-7. doi: 10.1016/j.yrtph.2018.03.001. Epub 2018 Mar 3.
4
A Case Study to Address a Gap in the Device-to-Vial Interface Stopper Push-in by Chemo Spikes.一个解决化疗加药器在瓶塞插入过程中设备与药瓶接口间隙问题的案例研究。
PDA J Pharm Sci Technol. 2019 Jan-Feb;73(1):92-109. doi: 10.5731/pdajpst.2018.008664. Epub 2018 Sep 19.
5
Comparison of closed system transfer devices for turnaround time and ease of use.封闭系统转移装置在周转时间和易用性方面的比较。
J Oncol Pharm Pract. 2019 Jul;25(5):1142-1151. doi: 10.1177/1078155218781900. Epub 2018 Jun 29.
6
Evaluation of Different Quality-Relevant Aspects of Closed System Transfer Devices (CSTDs).评估密闭式输液管路(CSTD)的不同质量相关方面。
Pharm Res. 2020 Apr 9;37(4):81. doi: 10.1007/s11095-020-02784-1.
7
Application of the 2015 proposed NIOSH vapor containment performance protocol for closed system transfer devices used during pharmacy compounding and administration of hazardous drugs.2015年美国国家职业安全与健康研究所(NIOSH)提出的用于药房配制和使用危险药物期间的密闭系统转移装置的蒸气控制性能协议的应用。
J Oncol Pharm Pract. 2019 Jul;25(5):1160-1166. doi: 10.1177/1078155218787256. Epub 2018 Jul 24.
8
Identification and reduction of hazardous drug surface contamination through the use of a novel closed-system transfer device coupled with a point-of-care hazardous drug detection system.通过使用新型封闭系统转移装置结合即时护理危险药物检测系统来识别和减少危险药物的表面污染。
Am J Health Syst Pharm. 2023 Mar 21;80(7):435-444. doi: 10.1093/ajhp/zxac336.
9
Review of studies examining microbial contamination of vials used for preparations done with closed-system drug transfer devices.研究综述:考察用于密闭式药物传输装置制备的小瓶中微生物污染情况。
Eur J Hosp Pharm. 2021 Mar;28(2):65-70. doi: 10.1136/ejhpharm-2019-001913. Epub 2019 May 15.
10
Developing a flowchart to evaluate the use of Closed System Drug-Transfer Devices with monoclonal antibodies: Focus on the clinical trial setting.制定流程图以评估在临床试验环境中使用含单克隆抗体的密闭式药物传输装置。
J Oncol Pharm Pract. 2023 Dec;29(8):2014-2022. doi: 10.1177/10781552231199412. Epub 2023 Sep 8.

引用本文的文献

1
Source apportionment and quantification of liquid and headspace leaks from closed system drug-transfer devices via Selected Ion Flow Tube Mass Spectrometry (SIFT-MS).通过选择离子流管质谱法(SIFT-MS)对密闭系统药物传输装置的液体和顶空泄漏进行源分配和定量。
PLoS One. 2021 Nov 4;16(11):e0258425. doi: 10.1371/journal.pone.0258425. eCollection 2021.